
The Digital In Vivo Alliance (DIVA) is a collaborative organization focused on advancing novel therapies by integrating digital measures into AI-enhanced in vivo research. Their mission is to develop, validate, and promote the adoption of digital measures for preclinical in vivo research, aiming to accelerate drug discovery and improve the reproducibility of studies. DIVA members share data, algorithms, and best practices to enhance the understanding of health and disease through digital biomarkers. They are working on a foundational set of behavioral and physiological biomarkers applicable to various disease models, with a goal of establishing regulatory confidence and acceptance for these innovative capabilities.

The Digital In Vivo Alliance (DIVA) is a collaborative organization focused on advancing novel therapies by integrating digital measures into AI-enhanced in vivo research. Their mission is to develop, validate, and promote the adoption of digital measures for preclinical in vivo research, aiming to accelerate drug discovery and improve the reproducibility of studies. DIVA members share data, algorithms, and best practices to enhance the understanding of health and disease through digital biomarkers. They are working on a foundational set of behavioral and physiological biomarkers applicable to various disease models, with a goal of establishing regulatory confidence and acceptance for these innovative capabilities.